|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 32 studies with search of: | "Kidney Diseases, Cystic" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
|
||||
| 2 | Recruiting |
UAB Recessive PKD Research and Translational Core Center
|
||||
| 3 | Recruiting |
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
||||
| 4 | Recruiting |
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease
|
||||
| 5 | Recruiting |
Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
|
||||
| 6 | Recruiting |
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
|
||||
| 7 | Active, not recruiting |
Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
||||
| 8 | Recruiting |
Evaluation of Autosomal Recessive Polycystic Kidney Disease and Congenital Hepatic Fibrosis
|
||||
| 9 | Recruiting |
A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
|
||||
| 10 | Active, not recruiting |
High Water Intake to Slow Progression of Polycystic Kidney Disease
|
||||
| 11 | Completed |
Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
|
||||
| 12 | Recruiting |
Efficacy, Safety and Tolerability of Everolimus in Preventing End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
|
||||
| 13 | Available |
Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction
|
||||
| 14 | Active, not recruiting |
"TEMPO 3/4 Trial" Tolvaptan Efficacy and Safety in Management of Polycystic Kidney Disease and Its Outcomes
|
||||
| 15 | Active, not recruiting |
Octreotide in Severe Polycystic Liver Disease
|
||||
| 16 | Not yet recruiting |
CCB Safety Study in Treatment of Hypertension of ADPKD
|
||||
| 17 | Recruiting |
Polycystic Kidney Disease Data Repository
|
||||
| 18 | Not yet recruiting |
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
||||
| 19 | Recruiting |
Everolimus on CKD Progression in ADPKD Patients
|
||||
| 20 | Recruiting |
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-32) |
|